President and Chief Executive Officer
Jack Phillips has served as President and Chief Executive Officer of Accelerate Diagnostics since February 2020. Mr. Phillips joined the company in September of 2019 as Chief Operating Officer. From 2010 to 2019, Mr. Phillips served as President and CEO of Roche Diagnostics North America, the world leader in in-vitro diagnostics. During this time, Jack also served as a member of the Roche Global Diagnostics Leadership Team. Before joining Roche Diagnostics, Mr. Phillips served as Senior Vice President of Commercial Operations, North America at Ventana Medical Systems, a member of the Roche Group, and the world leader in tissue-based cancer diagnostics. Mr. Phillips has also served in commercial leadership roles at Bayer Diagnostics and Motorola. His board appointments include Chairman of the Board for Central Indiana Corporate Partnership in Indianapolis, IN, and member of the AdvaMedDx Board of Directors in Washington, D.C.
Chief Financial Officer
Steve Reichling has served as the Chief Financial Officer of the company since September 2012. Prior to joining the company, Mr. Reichling served as general manager of Spring Bioscience Corp., a R&D and research products subsidiary of Roche Diagnostics. From January 2003 to December 2009, Mr. Reichling held various finance, accounting and operations leadership roles at Roche Diagnostics and Ventana Medical Systems, Inc., including Director of Finance and Operations, Manager of Business Development Finance, and head of Internal Audit and Sarbanes Oxley Compliance. From October 2002 to January 2003, Mr. Reichling was an auditor at Ernst & Young LLP. Mr. Reichling received his B.A. in accounting and entrepreneurship from the University of Arizona.
Chief Scientific Officer
Romney Humphries, PhD, D(ABMM), M(ASCP) serves as the Chief Scientific Officer of the company and is a Professor in Pathology at the University of Arizona. Prior to joining Accelerate, Dr. Humphries was the Section Chief for Clinical Microbiology and an Assistant Clinical Professor of Pathology and Laboratory Medicine at UCLA Medical Center. Dr. Humphries is well known for her interest and publications in the area of antimicrobial susceptibility testing, new diagnostic technologies, and her work to address common issues faced by clinical microbiology laboratories. She is author of more than 150 scientific peer-reviewed publications in journals such as Clinical Infectious Diseases and Journal of Clinical Microbiology and serves on a number of working groups and committees including the American Society for Microbiology, the Clinical Laboratory and Standards Institute, the U.S. Food and Drug Administration, and the World Health Organization. Dr. Humphries received her B.S. in Biochemistry from the University of Lethbridge in Alberta, Canada and her PhD from the University of Calgary. She completed her postdoctoral study at the UCLA David Geffen Medical School, Clinical Microbiology CPEP Program.
Chief Commercial Officer, Americas
Ron Price has served as Chief Commercial Officer, Americas since April of 2015. Mr. Price has over 20 years of commercial operations experience and a proven track record of leading sales and marketing teams to achieve double-digit revenue growth and strong bottom-line performance. Prior to joining the company, Mr. Price served as Vice President, Commercial Operations for Roche Point of Care managing all commercial responsibilities across three separate product lifecycles. In addition, Ron held a number of sales, marketing, and leadership roles with Ventana Medical Systems from 2001 to 2012 following 5 years at Bayer Healthcare Diagnostics. Mr. Price holds a B.S. in Clinical Laboratory Sciences, Cytology from the University of Oklahoma.
Senior Vice President, Head of Sales, EMEA
Cherif Amin Bousselham has served as the SVP, Head of Sales, EMEA since October of 2018. Prior to joining the company, Mr. Bousselham served as Business Development Manager of Acelity, a global advanced wound care company. From 2012 to 2015, Mr. Bousselham held various commercial operation roles at Johnson & Johnson, DePuy, and Synthes Orthopaedics. Mr. Bousselham received his B.S. in Biomedical Sciences from University College London and his M.B.A from IESE Business School.
Senior Vice President, Head of Global Customer Support
Laura Costa has been the SVP, Head of Global Customer Support since July 2019. Ms. Costa served as Head of EMEA (Europe, Middle East, Africa) Customer Support in the Barcelona office September 2017 through June of 2019 and previous to this role she joined the company in January 2016 as Head of Commercial Education. She is an international leader with 20 plus years of demonstrated success in a breadth of roles in diagnostics, medical device and laboratory sciences. Prior to joining the company, Ms. Costa served as Sr. Director of Support for The Binding Site, Inc. January 2015 – December 2015. She also held a variety of roles with increasing responsibility at Roche Diagnostics and Ventana Medical Systems, Inc. June 2004 – December 2014; including Director of Support, Director of Marketing- Point of Care, Medical Device/Diagnostics Sales, Manager of Sales Training, Marketing Manager for Latin America (LATAM). She also performed research and clinical studies as a Lab Manager in the Analytical Cytology Core Facility at the University of Texas at El Paso, April 1996 – May 2004. Ms. Costa holds a B.S. in Biology and a M.S in Biology from the University of Texas at El Paso.
Senior Vice President, Head of Global Marketing and Strategy
Chad Brueck has served as SVP, Head of Global Marketing & Strategy since February 2019 and has been with the company since November 2016, when he joined as Director of Strategic Marketing. Mr. Brueck has more than 15 years of experience creating winning strategies and executing commercial launches in life sciences and diagnostics. Prior to joining Accelerate, he held increasingly impactful roles in research and development, product management, marketing, and strategy at companies including Sigma-Aldrich, Promega, and Luminex. Mr. Brueck earned a B.S. in Biology from Eastern Illinois University, an M.A. in Biology from Washington University, and an M.B.A. from Colorado State University.
Senior Vice President , Head of Quality and Regulatory
Constance Bridges joined the company in January 2014 serving as the SVP, Head of Quality and Regulatory. Ms. Bridges has over 25 years of medical device and biologic industry experience in the combined fields of clinical, regulatory, quality, and engineering. Prior to joining the company, Ms. Bridges served in a variety of roles for Hologic including Director of Global Quality Systems, Director of Quality Systems, and Director of Clinical Operations. From 2001 to 2008, Ms. Bridges held various regulatory, quality, and compliance leadership roles at Focus Diagnostics, including Director of Regulatory Affairs. Prior to her tenure at Focus, Ms. Bridges worked in various positions of increasing responsibility at both Baxter and Johnson & Johnson. Ms. Bridges received her B.S. in Engineering from Kettering University, her M.B.A. from Pepperdine University, holds Regulatory Affairs Certification, and is a Certified Biomedical Auditor.
Senior Vice President, Head of Business Development
John Meduri has served as the SVP, Head of Business Development for Accelerate Diagnostics since March 2016. Prior to joining the company, Mr. Meduri held numerous commercial and business development roles at Becton Dickinson where he launched numerous IVD systems over his 33-year career with BD. John is an infectious-disease in-vitro diagnostic industry veteran with over 35 years of experience in bringing novel diagnostic platforms to the global market. He also supported the launch of the first internet-based antimicrobial resistance surveillance system, The TSN. Mr. Meduri holds a Master’s in Public Health through the Johns Hopkins Bloomberg School of Public Health, an MBA through the Wharton School of the University of Pennsylvania, an MBA through the Johns Hopkins Carey Business School and is also an ASCP-certified medical technologist.
Senior Vice President , Head of Research and Development
Parampal Deol, Ph.D, MBA has served as the SVP, Head of Research and Development since January 2020. Dr. Deol is a seasoned R&D professional with 22 years of Research experience, including 13 plus years of New Product Development and Life Cycle Management in Medical Device/IVD Industry. Before joining Accelerate, Parampal was Senior Director, US R&D Microbiology for bioMerieux where she held different positions in R&D from 2006 to 2019. She was responsible for driving the R&D Microbiology teams from concept to launch for Blood Culture, Identification and Susceptibility products for Clinical Diagnostics and Industrial applications for Blood Banks, Cellular Therapy and Biopharma. From 2005 to 2006, she worked on pre-clinical and new Drug development in the Drug Discovery division in Southern Research Institute, Birmingham, AL. In addition to successful product launches, she is also an author of several scientific publications and has many patents. Dr. Deol holds an MBA from North Carolina State University with a dual concentration in Innovation and Marketing Management. She completed her Ph.D from Post-Graduate Institute of Medical Education and Research, Chandigarh, India and has a post graduate diploma in Biotechnology from Panjab University, Chandigarh, a MS in Microbiology from Guru Nanak Dev university, Amritsar and a BS in Biology from Panjab University, Chandigarh. She has done her post-doctoral programs at All India Institute of Medical Science, New Delhi, Institute of Genomics and Integrative Biology, Delhi and University of Rochester Medical Center, Rochester, NY.
Senior Vice President, General Counsel
Michael Bridge has served as SVP, General Counsel of the company since October 2019. Mr. Bridge served as General Counsel for Enterprise Diversified, Inc. from 2017 to 2019. Mr. Bridge was Managing Partner of Ironwood Capital, L.P from 2013 to 2017. Previously, Mr. Bridge was Senior Vice President and General Counsel for JDA Software Group, Inc. from 1999 to 2013. Prior to his tenure at JDA, Mr. Bridge worked as in-house counsel for several technology companies, and as a corporate and securities associate at Piper & Marbury (a predecessor to DLA Piper). Mr. Bridge holds a B.A. in Political Science from the University of Southern California and a J.D. from Cornell University.
Senior Vice President, Head of Human Resources and Culture
Gretchen Strohminger has served as the SVP, Head of Human Resources and Culture since January 2018. In this role, she leads the HR team in talent management, leadership development, compensation, benefits, people tools and technologies and reinforcing a strong company culture. Prior to joining the company in 2015, Ms. Strohminger was a key HR Partner at various companies in the medical device, energy, and manufacturing industries. Ms. Strohminger started in her career as a Personnel Officer in the United States Air Force and Air National Guard from 1997 to 2006. Ms. Strohminger has an M.S. in Human Resources from Troy State University, a Bachelor’s of Social Work from Arizona State University and is a certified Senior Professional in Human Resources.